Last reviewed · How we verify

NCT06692608

Effects of an Isometric Training Session on Post-exercise Neuromuscular Function When Compared to Dynamic Strength Training

Completed NA Last updated 1 August 2025
What this trial tests

NA trial testing strength training in Strength Training Effects in 20 participants. Completed in 11 May 2025.

Timeline
20 November 2024
Primary endpoint
10 December 2024
11 May 2025

Quick facts

Lead sponsorUniversity of Maia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment20
Start date20 November 2024
Primary completion10 December 2024
Estimated completion11 May 2025
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

University of Maia

Who can join

Adults 18 to 35, male only, with Strength Training Effects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The existing literature shows that maximum strength can be improved through both dynamic and isometric strength training. However, there is a perception that dynamic training has a negative effect on short-term neuromuscular performance in soccer players. Hence, the aim of this study was to compare the neuromuscular impairment after isometric and dynamic training sessions in young soccer players.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of strength training

Trials testing the same drug.

Other recruiting trials for Strength Training Effects

Currently open trials in the same condition.

Other University of Maia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06692608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing